Wegovy
Wegovy is a once-weekly subcutaneous injectable medication containing the active ingredient semaglutide. It is indicated for chronic weight management in adults and pediatric patients (aged 12 and older) with obesity or overweight accompanied by weight-related medical conditions. It works as a GLP-1 receptor agonist to suppress appetite, delay gastric emptying, and enhance satiety. It comes in a range of dose strengths (0.25 mg, 0.5 mg, 1 mg, 1.7 mg, and 2.4 mg) and requires a step-up dosing sch
6,080 ج.م
● In Stock